Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

32 results about "Vancomycin Hydrochloride" patented technology

The hydrochloride salt of vancomycin, a branched tricyclic glycosylated peptide with bactericidal activity against most organisms and bacteriostatic effect on enterococci. At a site different from that of penicillins and cephalosporins, vancomycin binds tightly to the D-alanyl-D-alanine portion of cell wall precursors, thereby interfering with bacterial cell wall synthesis. This leads to activation of bacterial autolysins that destroy the cell wall by lysis. Vancomycin may also alter the permeability of bacterial cytoplasmic membranes and may selectively inhibit RNA synthesis.

Process of purifying vancomycin hydrochloride

Provided is a method of purifying a vancomycin from a fermentation broth of a microorganism containing vancomycin, including passing the fermentation broth of a microorganism containing vancomycin through a strong acid cation exchange resin, a weak base anion exchange resin, alumina and a hydrophobic absorbent resin sequentially.
Owner:SAMYANG BIOPHARMLS CORP +1

Refining method for vancomycin hydrochloride

The invention discloses a refining method for vancomycin hydrochloride. In the method, a vancomycin hydrochloride solution of which the purity is over 90 percent is refined into vancomycin hydrochloride of which the purity is over 95 percent; and in a refining process, solid-liquid separation is realized without using any organic solvent, and the yield is over 80 percent. Vancomycin in a mother solution obtained through solid-liquid separation can be returned to a previous separating process for recycling. The refining method is easy and convenient for operating, has high yield, and is a feasible industrial refining process.
Owner:FUJIAN BOMEI BIOLOGICAL TECH CO LTD

Topical vancomycin formulation and methods of use

Disclosed herein are methods, compositions, and kits for treating a skin condition caused by a bacterial infection at a skin depth with a topical ointment comprising vancomycin hydrochloride. Also disclosed herein are methods, compositions, and kits for testing susceptibility of vancomycin for treating a bacterial infection at a skin depth, and of optimizing a topical ointment therapeutic regimen.
Owner:KUROBE

Vancomycin hydrochloride medicine composition and method for preparing vancomycin hydrochloride medicine composition

The invention discloses a vancomycin hydrochloride medicine composition and a method for preparing the same. The vancomycin hydrochloride medicine composition comprises 10-60% of vancomycin hydrochloride, 30-90% of matrixes and 0-10% of lubricants, and preferably comprises 30-40% of vancomycin hydrochloride, 50-70% of matrixes and 2-8% of lubricants. The matrixes are one or two types of PEG (polyethylene glycol) 1000-6000, stearic acid and poloxamer 188, and the lubricants are one or two types of micro-powder silica gel, talc powder, sodium stearyl fumarate, sodium dodecyl sulfate and magnesium stearate. The vancomycin hydrochloride medicine composition can be in one of dosage forms of soft capsules, hard capsules and tablets. The vancomycin hydrochloride medicine composition and the method have the advantages that components in the vancomycin hydrochloride medicine composition are easily matched with one another, and medicines are high in stability; hot melting technologies are adopted in the method for preparing the vancomycin hydrochloride medicine composition, processes for producing the vancomycin hydrochloride medicine composition are simple, can be implemented conveniently and quickly, are stable and can be scaled up advantageously, and service dosage forms of the vancomycin hydrochloride can be broadened.
Owner:YUNG SHIN PHARMA IND KUNSHAN
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products